Oesophageal toxicity-impact of radiation dose, time, volume and chemotherapy

Oesophageal toxicity-impact of radiation dose, time, volume and chemotherapy

Bibliographic Details
Main Author:	Fenwick, J
Format:	Conference item
Published:	2007

Similar Items

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: A radiobiological investigation
by: Carrington, R, et al.
Published: (2015)

The effect of dose escalation on gastric toxicity when treating lower oesophageal tumours: a radiobiological investigation
by: Warren, S, et al.
Published: (2015)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
by: Millo, J, et al.
Published: (2003)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
by: Findlay, J, et al.
Published: (2016)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
by: den Boer, RB, et al.
Published: (2020)

Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma.
by: Jones, B, et al.
Published: (2007)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
by: Turkington, RC, et al.
Published: (2019)

Isotoxic dose escalation with real-time imaging on an MR-linac in lung radiation therapy
by: Bendall, L, et al.
Published: (2018)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER
by: Peto, R
Published: (1985)

Cone beam CT verification for oesophageal cancer - impact of volume selected for image registration.
by: Hawkins, M, et al.
Published: (2011)

Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
by: Holyoake, D, et al.
Published: (2018)

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
by: Holyoake, D, et al.
Published: (2017)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER - REPLY
by: Peto, R
Published: (1985)

Clinical and dosimetric factors impacting radiation pneumonitis in isotoxically dose-escalated NSCLC
by: Vivekanandan, S, et al.
Published: (2017)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
by: Gillies, R, et al.
Published: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
by: Gillies, R, et al.
Published: (2012)

Oesophageal and gastro-oesophageal junction tumours
by: Bird-Lieberman, E, et al.
Published: (2007)

Normal tissue doses during isotoxically dose escalated lung radiation therapy using MR-linacs
by: Bendall, L, et al.
Published: (2018)

Can protons reduce bone marrow toxicity in definitive chemoradiotherapy for oesophageal tumours?
by: Warren, S, et al.
Published: (2016)

The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial
by: Carrington, E, et al.
Published: (2016)

Adequate SIRT activity dose is as important as adequate chemotherapy dose – Authors' reply
by: Sharma, R, et al.
Published: (2017)

Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy
by: Holyoake, D, et al.
Published: (2017)

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
by: Holyoake, DLP, et al.
Published: (2018)

RATIONALE AND DESIGN OF THE GASTRANOX TRIAL ON A LOW-MOLECULAR-WEIGHT HEPARIN [LMWH], ENOXAPARIN, WITH CHEMOTHERAPY VS. CHEMOTHERAPY ALONE IN INOPERABLE GASTRIC AND GASTRO-OESOPHAGEAL CANCER
by: Kakkar, A, et al.
Published: (2010)

Delay differential equations and the dose-time dependence of early radiotherapy reactions.
by: Fenwick, J
Published: (2006)

A comparison of dose-volume constraints derived using peak and longitudinal definitions of late rectal toxicity.
by: Gulliford, S, et al.
Published: (2010)

Surgical specialty, surgical unit volume and mortality after oesophageal cancer surgery.
by: Leigh, Y, et al.
Published: (2009)

Adjuvant radiotherapy following neo-adjuvant chemotherapy and surgery in oesophageal cancer: a retrospective cohort study of survival
by: Teoh, S, et al.
Published: (2018)

Impact of dose-distribution uncertainties on rectal ntcp modeling. II: Uncertainty implications.
by: Fenwick, J
Published: (2001)

Vomiting in docetaxel chemotherapy: which to blame, dose or gene?
by: Jabir, Rafid, et al.
Published: (2014)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
by: Gillies, R, et al.
Published: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
by: Gillies, R, et al.
Published: (2012)

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
by: Gillies, R, et al.
Published: (2011)

Toxicity after cervical cancer treatment using radiotherapy and chemotherapy.
by: Jones, B
Published: (2009)

Impact of dose-distribution uncertainties on rectal ntcp modeling. I: Uncertainty estimates.
by: Fenwick, J, et al.
Published: (2001)

Dose-response relationships for radiation-related heart disease: impact of uncertainties in cardiac dose reconstruction
by: Ntentas, G, et al.
Published: (2020)

Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
by: Holyoake, D, et al.
Published: (2019)

Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
by: Dutton, S, et al.
Published: (2014)

Role of adjuvant radiotherapy following neo-adjuvant chemotherapy (NACT) and surgery in oesophageal cancer - a multi-centre retrospective cohort study
by: Teoh, S, et al.
Published: (2016)

High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed or refractory testicular cancer: a systematic review and meta-analysis
by: Briones, J, et al.
Published: (2024)